Michigan PICC-Associated Thrombosis (MAT) Score
Predicts risk of PICC-associated upper extremity DVT in hospitalised patients.
Score interpretation
Michigan Risk Score 0: symptomatic PICC-DVT 0.9 % (Chopra 2017).
→ Routine PICC care; use the fewest lumens and smallest catheter needed.
Michigan Risk Score 1–2: symptomatic PICC-DVT 1.6 %.
→ Routine PICC care; single lumen unless more are essential.
Michigan Risk Score 3–4: symptomatic PICC-DVT 2.7 %.
→ Review the indication and lumen number; consider an alternative device where appropriate (MAGIC).
Michigan Risk Score ≥ 5: symptomatic PICC-DVT 4.7 % (about 5-fold class I).
→ Weigh the PICC against alternative venous access; if placed, single lumen and smallest gauge, and monitor for arm swelling or pain.
Interpretation bands for the MAT Score. Apply clinical judgement and local guidance.
References
- Chopra V, Kaatz S, Conlon A, et al. The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis. J Thromb Haemost. 2017;15(10):1951-1962.
- Chopra V et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med. 2015;163(6 Suppl):S1–S40.
Related
Curated clinical cross-links plus same-class fallbacks.
- Unfractionated Heparin (Peripheral/Central Line Flush) · Anticoagulant flush / catheter maintenance
- Dalteparin · Low Molecular Weight Heparin — VTE Treatment / Cancer-Associated Thrombosis
- Phenytoin / Fosphenytoin · Antiepileptic — Status Epilepticus (Second-Line)
- Levetiracetam (IV) · Antiepileptic — Status Epilepticus (Second-Line)
- Ethambutol · Antitubercular — First-Line TB (RIPE Regimen, 'E')
- Pyrazinamide · Antitubercular — First-Line TB (RIPE Regimen, 'P')
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.